Collaborative Arrangement Milestones Global Sales And Regulatory Milestone Receivable Maximum Potential Monotherapy
Theravance Biopharma·Geographic·1 segment
Breakdown
Segments
European UnionView metric
| Segment | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|
| European Union | $10M | $10M | $10M |
| Total | $10M | $10M | $10M |